Supernus Pharmaceuticals | SUPN - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
Abbott USD 6.8B 1.72B 2026-03
ANI Pharmaceuticals USD 360.21M 49.04M 2026-06
Aurora Cannabis CAD 64.69M 8.33M 2026-03
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Canopy Growth CAD 364.68M 6.64M 2026-03
Cara Therapeutics USD 19.85M 883K 2026-03
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Eisai JPY 245.42B 56.22B 2026-03
Eli Lilly USD 8.95B 3.67B 2026-06
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Pacira USD 205.88M 61.57M 2026-06
Perrigo USD 357.2M 174.4M 2026-03
Pfizer USD 976M 727M 2026-06
Supernus Pharmaceuticals USD 179.95M 4.92M 2026-06
United Therapeutics USD 1.8B 523.5M 2026-06
Xeris Pharmaceuticals USD 121.75M 10M 2026-06